![Karen McTavish](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Karen McTavish worked as a Manager-Investor Relations & Communications at Mirati Therapeutics, Inc. from 1997 to 2011.
Ehemalige bekannte Positionen von Karen McTavish
Unternehmen | Position | Ende |
---|---|---|
MIRATI THERAPEUTICS | Public Communications Contact | 01.10.2011 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Mirati Therapeutics, Inc.
![]() Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |